Literature DB >> 6865905

Modification of the binding properties of muscarinic receptors by gallamine.

J M Stockton, N J Birdsall, A S Burgen, E C Hulme.   

Abstract

The interaction of gallamine with muscarinic receptors from different tissues has been investigated. Gallamine binds to a site distinct from the conventional muscarinic ligand binding site and modulates the binding of agonists and antagonists to the conventional binding site. In agreement with reported pharmacological studies, the effects of gallamine on the binding of muscarinic ligands are much greater in heart than in other tissues. These findings suggest the possibility of developing novel and selective muscarinic drugs.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6865905

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  72 in total

Review 1.  Allosteric drugs acting at muscarinic acetylcholine receptors.

Authors:  Magali Waelbroeck
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

2.  A Monod-Wyman-Changeux mechanism can explain G protein-coupled receptor (GPCR) allosteric modulation.

Authors:  Meritxell Canals; J Robert Lane; Adriel Wen; Peter J Scammells; Patrick M Sexton; Arthur Christopoulos
Journal:  J Biol Chem       Date:  2011-11-15       Impact factor: 5.157

Review 3.  Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.

Authors:  Terry Kenakin; Laurence J Miller
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

Review 4.  Allosteric activators of muscarinic receptors as novel approaches for treatment of CNS disorders.

Authors:  Gregory J Digby; Jana K Shirey; P Jeffrey Conn
Journal:  Mol Biosyst       Date:  2010-06-25

Review 5.  The mass action equation in pharmacology.

Authors:  Terry Kenakin
Journal:  Br J Clin Pharmacol       Date:  2015-12-21       Impact factor: 4.335

6.  Brain soluble fractions which modulate Na+, K+-ATPase activity likewise modify muscarinic receptor.

Authors:  G Rodríguez de Lores Arnaiz; P Schneider; C Peña
Journal:  Neurochem Res       Date:  1999-11       Impact factor: 3.996

Review 7.  G Protein-Coupled Receptors in Asthma Therapy: Pharmacology and Drug Action.

Authors:  Stacy Gelhaus Wendell; Hao Fan; Cheng Zhang
Journal:  Pharmacol Rev       Date:  2020-01       Impact factor: 25.468

8.  Muscarinic suppression of the M-current in the rat sympathetic ganglion is mediated by receptors of the M1-subtype.

Authors:  N V Marrion; T G Smart; S J Marsh; D A Brown
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

9.  Quantitative studies of allosteric effects by biointeraction chromatography: analysis of protein binding for low-solubility drugs.

Authors:  Jianzhong Chen; David S Hage
Journal:  Anal Chem       Date:  2006-04-15       Impact factor: 6.986

10.  Interaction of the neuromuscular blocking drugs alcuronium, decamethonium, gallamine, pancuronium, ritebronium, tercuronium and d-tubocurarine with muscarinic acetylcholine receptors in the heart and ileum.

Authors:  J Nedoma; N A Dorofeeva; S Tucek; S A Shelkovnikov; A F Danilov
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-04       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.